do glp 1 reduce cancer risk Glucagon-like peptide-1 medicines and cancer

Researchers from Penn Medicine found that women taking GLP-1 drugs are less likely to be diagnosed with breast cancer., @drcelinegounder breaks down the study’s findings and whether the drugs caused

23.83

★★★★☆4.8 (126)

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting. The

28.22

★★★★★4.9 (98)

Glucagon-like peptide-1 medicines and cancer

21.69

★★★★★5.0 (157)

Can obesity meds also reduce cancer risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked

25.60

★★★★★4.7 (84)

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

23.14

★★★★★4.9 (203)

Could popular diabetes and weight-loss drugs influence blood cancer risk? GLP-1 receptor agonists—drugs like Ozempic and Wegovy ( Novo Nordisk Foundation ) —are widely prescribed for type 2 diabetes and weight loss

25.90

★★★★★5.0 (176)

Both GLP-1 Receptor Agonists and Bariatric Surgery Lower the Risk of Weight-Related Cancer in Patients With Obesity

20.58

★★★★★4.8 (132)